The effect of renal failure and hyperkalemia on the duration of pancuronium neuromuscular blockade in man.
D000328:Adult; D000368:Aged; D000731:Androstanes / Q000494:pharmacology*; D001830:Body Surface Area; D002245:Carbon Dioxide / Q000097:blood; D003404:Creatinine / Q000097:blood; D006801:Humans; D006947:Hyperkalemia / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000503:physiopathology*; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects*; D009467:Neuromuscular Depolarizing Agents; D009469:Neuromuscular Junction / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D010197:Pancuronium / Q000008:administration & dosage / Q000494:pharmacology; D011188:Potassium / Q000097:blood; D009435:Synaptic Transmission / Q000187:drug effects; D013696:Temperature; D013997:Time Factors
D000731:Androstanes; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D002245:Carbon Dioxide; D003404:Creatinine; D010197:Pancuronium; D011188:Potassium